CD52 is a novel target for the treatment of FLT3-ITD-mutated myeloid leukemia.
Karnan S, Hanamura I, Ota A, Takasugi S, Nakamura A, Takahashi M, Uchino K, Murakami S, Wahiduzzaman M, Quang Vu L, Rahman ML, Hasan MN, Hyodo T, Konishi H, Tsuzuki S, Yoshikawa K, Suzuki S, Ueda R, Ejiri M, Hosokawa Y, Takami A.
Karnan S, et al. Among authors: nakamura a.
Cell Death Discov. 2021 May 25;7(1):121. doi: 10.1038/s41420-021-00446-8.
Cell Death Discov. 2021.
PMID: 34035227
Free PMC article.